TROG 05.01 (POST)

Primary Sponsor: Trans Tasman Radiation Oncology Group (TROG)

Title

Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck (POST)

Summary

For patients who have undergone surgery for high-risk skin cancer of the head and neck, this study aims to determine whether there is a difference in time to loco-regional relapse (cancer coming back in the same area) between patients treated with concurrent chemo-radiotherapy (using the chemo drug Carboplatin) versus those participants who were treated with radiotherapy alone.

Final accrual

321

Trial Status

Closed to follow-up, March 2016

Trial chairperson

Professor Sandro Porceddu,
Princess Alexandra Hospital,
QLD

Trial contact

Professor Sandro Porceddu,
Email: sandro.porceddu@health.qld.gov.au

Further information

TROG 05.01 on Australian Cancer Trials website

Trial resources for TROG members

TROG 05.01 member page